Claims: The United States and European perspective

Agro Food Industry Hi-Tech

Volumn 22, Issue 4, 2011, Pages 5-7

  Dolan, Laurie C ^a   Chaumont, Violaine ^b  

^a Burdock Group   (United States)

^b RNI Consulting Regulations Nutrition International   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053353088     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Institute of Medicine Food and Nutrition Board DRI tables (2011). Available at http://fnic.nal.usda.gov/nal-display/index.php?info-center= 4&tax-level=3&tax-subject=256&topic-id=1342&level3id=5140.
2. Regulation (EC) No 1924/2006 (2007). Available at http://eur-lex. europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:012:0003:0018:E N:PDF.
3. Commission Regulation (EU) No 116/2010 (2010). Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:03:7:0016:0018: EN:PDF.
4. Commission Directive 2008/100/EC (2008). Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:285:0009:001 2:EN:PDF.
5. Federal Trade Commission (2010). FTC warns marketers of children's omega-3 fatty acid supplements that claims about brain and vision benefits may be deceptive. Available at http://www.ftc.gov/opa/2010/02/omega.shtm.
6. EFSA (2011), Nutrition and health claims - scientific documents. Available at http://www.efsa.europa.eu/en/topics/topic/nutrition.htm.
7. Federal Register Final Rule 65 FR 999 (2000). Available at http:// www.fda.gov/Food/DietarySupplements/Guidance ComplianceRegulatoryInformation/ RegulationsLaws/ ucm107387.htm.
8. EFSA (2009), Scientific opinion on health claims related to calcium. Available at http://www.efsa.europa.eu/en/scdocs/doc/1210.pdf.
9. EFSA (2010), Scientific opinion in relation to the authorization procedure for health claims on calcium and vitamin D in the reduction of the risk of osteoporotic fractures. Available at http://www.efsa.europa.eu/fr/ scdocs/doc/1609.pdf.
10. FDA (2011), Summary of qualified health claims subject to enforcement discretion. Available at http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ QualifiedHealthClaims/ ucm073992.htm.
11. EFSA (2010), Scientific opinion on health claims related to calcium. Available at http://www.efsa.europa.eu/fr/scdocs/doc/1725.pdf.
12. FDA (2009), Claims. Guidance for industry: A food labeling guide. Available at http://www.fda.gov/food/guidance complianceregulatoryinformation/ guidance documents/ foodlabelingnutrition/foodlabelingguide/ucm064908.htm.
13. EFSA (2010), Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA). and docosapentaenoic acid (DPA), Available at http://www.efsa.europa.eu/fr/scdocs/ doc/1796.pdf.
14. EFSA (2009), Scienfific Opinion on the substantiation of health claims related to EPA, DHA. and DPA, Available at http://www.efsa. europa.eu/fr/scdocs/ doc/1263.pdf.
15. EFSA (2010), Scientific Opinion on the substantiation of health claims related to docosohexaenoic acid (DHA). Available at http://www. efsa.europa.eu/fr/scdocs/doc/1734.pdf.
16. EFSA (2009), Scientific Opinion. Enfamil®Premium and visual development. Available at http://www.efsa.europa.eu/en/scdocs/doc/1004.pdf.
17. EFSA (2009), Scientific Opinion. Lipil®and visual development, Available at http://www.efsa.europa.eu/en/scdocs/doc/1003.pdf.